Design Therapeutics, Inc.
DSGN
$9.77
$0.839.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.16% | -25.65% | 4.22% | 25.84% | 33.97% |
| Total Depreciation and Amortization | 5.13% | 7.73% | 11.07% | 10.99% | 11.85% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.35% | 72.63% | 27.39% | -2.23% | -31.07% |
| Change in Net Operating Assets | 181.93% | 138.61% | 114.10% | -236.40% | -273.15% |
| Cash from Operations | -13.49% | 0.77% | 11.42% | 26.39% | 24.34% |
| Capital Expenditure | 56.68% | 67.20% | 40.38% | -32.81% | 29.01% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.06% | -65.13% | -41.57% | -16.10% | 3.45% |
| Cash from Investing | -23.81% | -65.11% | -41.58% | -16.33% | 3.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -8.92% | -15.07% | -30.65% | -29.14% | 112.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -8.92% | -15.07% | -30.65% | -29.14% | 112.75% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -738.73% | -240.50% | -2,775.17% | 125.72% | 116.37% |